NAL Pharmaceutical Group Limited

Hong Kong, 
Hong Kong
  • Booth: 846

NAL Pharmaceutical Group Limited is an emerging drug developer that applies Company’s proprietary Drug Delivery System (DDS) platform technologies, including Fast-onset Bio-FX Sublingual Orally Dissolving Film DDS, Bio-D3 Transdermal Patch DDS, Bio-CR Oral Controlled-Release DDS, Bio-NN Nanoparticle Injectable DDS, and Bio-MM Microsphere Extended-Release Injectable DDS, to develop difficult-to-formulate, difficult-to-duplicate, and/or difficult-to-manufacture dosage forms and delivery systems.

Brands: NAL's DDS products are focused in the areas of oncology, pain management, CNS, Alzheimer's disease and others, including Rivastigmine Patch, LIDO KING Patch (Lidocaine 4% OTC) and Lidocaine 5% Patch.

For Technical Support with this webpage, please contact support.